Assignee profile:

Stealth BioTherapeutics Corp

City:

Monaco

Country:

Monaco

Published Applications:

51

Last publication date:

2021-12-30

Patent Grants:

38

Last grant date:

2023-10-03

Top Inventors for applications by Stealth BioTherapeutics Corp

These are the the leading inventors for applications assigned to Stealth BioTherapeutics Corp:

Recent patent applications by Stealth BioTherapeutics Corp

Stealth BioTherapeutics Corp based in Monaco, MC has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-12-30 ✅ Patent 11,771,734 granted on 2023-10-03
US20210401923A1
Human necessities

Methods and compositions for the prevention or treatment of Barth syndrome

#2 | 2021-05-27 ✅ Patent 11,612,633 granted on 2023-03-28
US20210154259A1
Human necessities

Methods and compositions for preventing or treating ophthalmic conditions

#3 | 2021-05-06
US20210130402A1
Chemistry; metallurgy

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#4 | 2021-02-18
US20210046146A1
Human necessities

METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE

#5 | 2021-02-11 ✅ Patent 12,065,511 granted on 2024-08-20
US20210040149A1
Chemistry; metallurgy

Aromatic-cationic peptides and uses of same

#6 | 2021-02-11
US20210038677A1
Human necessities

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY

#7 | 2021-01-28 ✅ Patent 11,366,104 granted on 2022-06-21
US20210025873A1
Physics

Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening

#8 | 2021-01-28
US20210023160A1
Human necessities

METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY

#9 | 2020-12-31
US20200407396A1
Chemistry; metallurgy

METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE

#10 | 2020-12-24
US20200397850A1
Human necessities

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY

#11 | 2020-12-03 ✅ Patent 11,376,304 granted on 2022-07-05
US20200376072A1
Human necessities

Methods and compositions for the prevention and treatment of disease

#12 | 2020-11-05 ✅ Patent 11,083,772 granted on 2021-08-10
US20200345803A1
Human necessities

Methods and compositions for the prevention or treatment of Barth Syndrome

#13 | 2020-10-15 ✅ Patent 11,141,456 granted on 2021-10-12
US20200323947A1
Human necessities

Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof

#14 | 2020-10-01 ✅ Patent 12,037,414 granted on 2024-07-16
US20200308221A1
Chemistry; metallurgy

Processes for preparing pharmaceutically relevant peptides

#15 | 2020-07-16 ✅ Patent 11,420,998 granted on 2022-08-23
US20200223887A1
Chemistry; metallurgy

Aromatic-cationic peptides and methods for using same

#16 | 2020-05-21
US20200157145A1
Chemistry; metallurgy

NEUTRAL-CATIONIC PEPTOIDS AND USES THEREOF

#17 | 2020-04-16
US20200113966A1
Human necessities

METHODS AND COMPOSITIONS FOR REGULATING SRCA2A EXPRESSION LEVELS IN MYOCARDIAL INFARCTION

#18 | 2020-01-23 ✅ Patent 10,696,716 granted on 2020-06-30
US20200024308A1
Chemistry; metallurgy

Pharmaceutically relevant aromatic-cationic peptides

#19 | 2019-12-26 ✅ Patent 10,835,573 granted on 2020-11-17
US20190388493A1
Human necessities

Methods for treating Friedreich's ataxia by an aromatic-cationic peptide to increase frataxin protein levels

#20 | 2019-12-12
US20190374596A1
Human necessities

PEPTIDE THERAPEUTICS AND METHODS FOR USING SAME

#21 | 2019-12-05
US20190365846A1
Human necessities

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY

#22 | 2019-11-14 ✅ Patent 10,646,539 granted on 2020-05-12
US20190343913A1
Human necessities

Methods and compositions for the treatment of neuropathy and hyperalgesia

#23 | 2019-10-31
US20190328822A1
Human necessities

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING DOMINANT OPTIC ATROPHY

#24 | 2019-01-03 ✅ Patent 10,525,098 granted on 2020-01-07
US20190000915A1
Human necessities

Methods for the regulation of matrix metalloproteinase expression

#25 | 2018-07-12 ✅ Patent 10,744,178 granted on 2020-08-18
US20180193405A1
Human necessities

Methods and compositions for the prevention and treatment of disease

#26 | 2018-05-31 ✅ Patent 11,083,771 granted on 2021-08-10
US20180147251A1
Human necessities

Methods and compositions for the prevention or treatment of Barth Syndrome

#27 | 2018-02-15 ✅ Patent 10,633,415 granted on 2020-04-28
US20180044378A1
Chemistry; metallurgy

Processes for preparing pharmaceutically relevant peptides

#28 | 2017-11-30 ✅ Patent 10,279,008 granted on 2019-05-07
US20170340695A1
Human necessities

Methods and compositions for increasing the dose of a chemotherapeutic agent

#29 | 2017-11-16 ✅ Patent 10,188,692 granted on 2019-01-29
US20170326197A1
Human necessities

Methods and compositions for preventing or treating ophthalmic conditions

#30 | 2017-11-09 ✅ Patent 10,702,577 granted on 2020-07-07
US20170319647A1
Human necessities

Combination therapies using cyclosporine and aromatic cationic peptides

#31 | 2017-07-13 ✅ Patent 10,576,124 granted on 2020-03-03
US20170196933A1
Human necessities

Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof

#32 | 2017-05-25 ✅ Patent 10,627,392 granted on 2020-04-21
US20170146521A1
Physics

Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening

#33 | 2017-03-30 ✅ Patent 10,322,159 granted on 2019-06-18
US20170087204A1
Human necessities

Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury

#34 | 2017-02-02
US20170028015A1
Human necessities

METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE

#35 | 2016-12-29
US20160376309A1
Chemistry; metallurgy

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#36 | 2016-11-24 ✅ Patent 10,221,213 granted on 2019-03-05
US20160340389A1
Chemistry; metallurgy

Pharmaceutically relevant aromatic-cationic peptides

#37 | 2016-10-13 ✅ Patent 9,943,563 granted on 2018-04-17
US20160296589A1
Human necessities

Compositions and methods for treating vitiligo

#38 | 2016-09-15 ✅ Patent 9,982,014 granted on 2018-05-29
US20160264623A1
Chemistry; metallurgy

Tetrapeptide compound and method for producing same

#39 | 2016-08-11 ✅ Patent 9,687,519 granted on 2017-06-27
US20160228487A1
Human necessities

Methods and compositions for the prevention or treatment of barth syndrome

#40 | 2016-07-07 ✅ Patent 10,047,395 granted on 2018-08-14
US20160194708A1
Chemistry; metallurgy

Methods and compositions for detecting and diagnosing diseases and conditions

#41 | 2016-06-02 ✅ Patent 10,293,020 granted on 2019-05-21
US20160151446A1
Human necessities

Peptide therapeutics and methods for using same

#42 | 2016-06-02 ✅ Patent 9,884,085 granted on 2018-02-06
US20160151445A1
Human necessities

Methods for the regulation of matrix metalloproteinase expression

#43 | 2016-05-05 ✅ Patent 9,877,997 granted on 2018-01-30
US20160120931A1
Human necessities

Methods and compositions for regulating SRCA2A expression levels in myocardial infarction

#44 | 2016-03-03 ✅ Patent 9,549,963 granted on 2017-01-24
US20160058825A1
Human necessities

Methods and compositions for preventing or treating ophthalmic conditions

#45 | 2016-01-07 ✅ Patent 10,793,597 granted on 2020-10-06
US20160002293A1
Chemistry; metallurgy

Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation

#46 | 2015-10-08 ✅ Patent 10,201,585 granted on 2019-02-12
US20150283200A1
Human necessities

Methods for treatment of atherosclerosis

#47 | 2015-06-11 ✅ Patent 10,188,693 granted on 2019-01-29
US20150157685A1
Human necessities

Methods for treatment of atherosclerosis

#48 | 2015-03-26 ✅ Patent 9,636,378 granted on 2017-05-02
US20150087595A1
Human necessities

Methods and compositions for the prevention and treatment neuropathy

#49 | 2014-12-11 ✅ Patent 9,561,258 granted on 2017-02-07
US20140364370A1
Human necessities

Combination therapies using cyclosporine and aromatic cationic peptides

#50 | 2014-08-21 ✅ Patent 9,988,422 granted on 2018-06-05
US20140235529A1
Chemistry; metallurgy

Aromatic-cationic peptides and methods for using same

#51 | 2013-08-01 ✅ Patent 9,345,738 granted on 2016-05-24
US20130196921A1
Human necessities

Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury

Also check out Stealth BioTherapeutics Corp's (Monaco, Monaco) applicant profile with 25 patent applications submitted.

AssigneeID:

117129 ⎘